Danone S.A. (GPDNF)
| Previous close | 62.88 |
| Open | 60.33 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 60.33 - 60.33 |
| 52-week range | 54.10 - 67.93 |
| Volume | |
| Avg. volume | 2,868 |
| Market cap | 38.724B |
| Beta (5Y monthly) | 0.43 |
| PE ratio (TTM) | 41.32 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.27 (3.61%) |
| Ex-dividend date | 03 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
Danone acquires Functional Formularies
Press release – Paris, May 01, 2024 Danone acquires Functional Formularies Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital. As part of the Renew Danone strategy, this acquisition strengthens Danone’s Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges. Juergen Esser, Deputy CEO and CFO, said: “As a global leader in Medical Nutriti
- GlobeNewswire
Danone successfully issues a €700 million bond
Press Release – Paris, April 26, 2024 Danone successfully issues a €700 million bond Danone announces that it has issued today a €700 million bond with a 6-year maturity and a 3.481% coupon. In line with the company’s active liquidity management, this issue enables Danone to enhance its funding flexibility while extending the maturity of its debt. The settlement is expected to take place on May 3, 2024 and the bonds will be listed on Euronext Paris. The bond issue was widely subscribed by a dive
- GlobeNewswire
Danone: 2024 Danone Shareholders’ Meeting: approval of all resolutions
Press Release – Paris, April 25, 2024 2024 Danone Shareholders’ Meeting: approval of all resolutions Danone’s Shareholders’ Meeting was held today, chaired by Gilles Schnepp, Chairman of the Board of Directors. 73.58% of Danone’s total outstanding share capital was present or represented in this Shareholders’ Meeting. Danone’s shareholders approved all resolutions submitted to its approval by the Board of Directors, including the statutory and consolidated financial statements for the 2023 fisca
